Progenity Stock

progenity.comHealthcare / Other HealthcareFunding to Date: $177.5MM

Progenity is a provider of highly-complex molecular diagnostic testing allowing healthcare providers to access the most advanced genomic technology to guide patient care at critical life stages.

Register To Buy and Sell Shares

For more details on financing and valuation for Progenity, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Progenity’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Progenity.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Eric d'Esparbes
Chief Financial Officer
Sami Shihabi
Chief Commercial Officer
Jared Kearns
Chief Information Officer
Allan Bombard MD
Chief Medical Officer
Harry Stylli Ph.D
Chairman and Chief Executive Officer
Matthew Cooper Ph.D
Chief Scientific Officer

Board Members

Harry Stylli Ph.D
John Bigalke
Samuel Nussbaum MD
Brian Kotzin
Jeffrey Alter
Lynne Powell
Howard Slutsky
Jeffrey Ferrell
Athyrium Capital Management

Frequently Asked Questions About Progenity’s Stock

Can you buy Progenity’s stock?
Progenity is not publicly traded on NYSE or NASDAQ in the U.S. To buy Progenity’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Progenity’s stock?
Yes, you can sell stock of a private company like Progenity. Forge can help you sell your Progenity stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Progenity’s stock price?
Progenity is a privately held company and therefore does not have a public stock price. However, you may access Progenity’s private market stock price with Forge Data.
What is Progenity’s stock ticker symbol?
Progenity does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Progenity stock has been up nearly 58% in the past five trading days and more than 170% since early October. As PROG keeps marching higher, is it too late for investors to jump in now?
Progenity stock has been up nearly 58% in the past five trading days and more than 170% since early October. As PROG keeps marching higher, is it too late for investors to jump in now?
Progenity, Natera Jointly Request Dismissal of Patent Litigation
Progenity sought a declaratory judgment from a California court last year that its Innatal NIPT test didn't infringe six patents held by Natera.
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Progenity, Inc. (PROG)
LOS ANGELES, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 27, 2020 deadline to...
Updated on: Jun 16, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.